Tyra Biosciences, Inc.
Tyra Biosciences, Inc. (TYRA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · TYRA · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
14
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Tyra Biosciences, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
TYRA insider buying and selling by quarter
TYRA insider selling · TYRA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · TYRA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
TYRA executive sell shares · TYRA board member insider trading · TYRA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 5, 2026 | Warner Douglas J Chief Medical Officer | Award | 25,000 | — | Form 4 |
| May 5, 2026 | Fuhrman Alan CFO | Award | 20,000 | — | Form 4 |
| May 5, 2026 | Harris Todd President and CEO · Director | Award | 79,000 | — | Form 4 |
| May 5, 2026 | Ashar Bhavesh COO | Award | 15,013 | — | Form 4 |
| May 5, 2026 | Rueb Yuliya Vice President, Finance (PAO) | Award | 8,333 | — | Form 4 |
| Mar 26, 2026 | KAPLAN GILLA Director | Option | 53,172 | $120K | Form 4 |
| Mar 25, 2026 | KAPLAN GILLA Director | Option | 14,295 | $32K | Form 4 |
| Mar 25, 2026 | KAPLAN GILLA Director | Sale | 14,295 | $529K | Form 4 |
| Mar 26, 2026 | KAPLAN GILLA Director | Other | 53,172 | $2.01M⚡ | Form 4 |
| Mar 13, 2026 | Fuhrman Alan CFO | Award | 1,376 | $13K | Form 4 |
| Mar 13, 2026 | Harris Todd President and CEO · Director | Award | 1,463 | $13K | Form 4 |
| Feb 12, 2026 | Bensen Daniel Chief Discovery Officer | Sale | 2,128 | $67K | Form 4 |
| Feb 12, 2026 | Bensen Daniel Chief Discovery Officer | Sale | 5,872 | $196K | Form 4 |
| Jan 12, 2026 | Bensen Daniel Chief Discovery Officer | Sale | 6,983 | $199K | Form 4 |
| Jan 12, 2026 | Bensen Daniel Chief Discovery Officer | Sale | 1,017 | $30K | Form 4 |
| Dec 19, 2025 | MORE ROBERT J Director | Sale | 10,000 | $250K | Form 4 |
| Dec 12, 2025 | Bensen Daniel Chief Discovery Officer | Sale | 8,000 | $181K | Form 4 |
| Nov 21, 2025 | MORE ROBERT J Director | Sale | 246,871 | $5.00M⚡ | Form 4 |
| Nov 18, 2025 | Bensen Daniel COO | Sale | 75,633 | $1.22M⚡ | Form 4 |
| Nov 19, 2025 | Bensen Daniel COO | Sale | 49,956 | $815K | Form 4 |
| Nov 13, 2025 | Bensen Daniel COO | Sale | 1,111 | $18K | Form 4 |
| Nov 14, 2025 | Bensen Daniel COO | Sale | 110,228 | $1.77M⚡ | Form 4 |
| Nov 17, 2025 | Bensen Daniel COO | Sale | 18,572 | $299K | Form 4 |
| Nov 17, 2025 | Bensen Daniel COO | Sale | 1,500 | $26K | Form 4 |
| Sep 15, 2025 | Fuhrman Alan CFO | Award | 701 | $6K | Form 4 |
Harris Todd
President and CEO · Director
Date
Mar 13
Shares
1,463
Price
$9.13
Value
$13K
Bensen Daniel
Chief Discovery Officer
Date
Feb 12
Shares
2,128
Price
$31.50
Value
$67K
Bensen Daniel
Chief Discovery Officer
Date
Feb 12
Shares
5,872
Price
$33.37
Value
$196K
Bensen Daniel
Chief Discovery Officer
Date
Jan 12
Shares
6,983
Price
$28.44
Value
$199K
Bensen Daniel
Chief Discovery Officer
Date
Jan 12
Shares
1,017
Price
$29.08
Value
$30K
Bensen Daniel
Chief Discovery Officer
Date
Dec 12
Shares
8,000
Price
$22.64
Value
$181K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About TYRA insider trading
TYRA insider trades
Tyra Biosciences, Inc. (TYRA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Bensen Daniel (Chief Discovery Officer), KAPLAN GILLA (Director), Fuhrman Alan (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. TYRA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Tyra Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
TYRA insider trading · 5 questionsThe insiders of Tyra Biosciences, Inc. (TYRA) include executives and directors such as Bensen Daniel (Chief Discovery Officer), KAPLAN GILLA (Director), Fuhrman Alan (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026